高通量篩檢市場：按產品/服務、技術、應用、最終用戶和地區分類。

預計到2026年，高通量篩檢市場規模將達到289.7億美元，2033年將達到597.6億美元。預計從2026年到2033年，該市場將以10.9%的複合年成長率成長。

全球高通量篩檢市場是製藥和生物技術產業的重要組成部分，它透過自動化篩檢技術革新了藥物發現和開發流程。高通量篩檢使研究人員能夠快速進行數百萬次化學、遺傳或藥理學測試，從而顯著加快活性化合物、抗體或調控特定生物分子路徑基因的鑑定。這種先進的調查方法已成為現代藥物研究的必備要素，使機構能夠以前所未有的速度和效率處理龐大的化合物庫。

這項技術涵蓋多種篩檢平台，服務於不同的研究目標，例如基於細胞的檢測、生化檢測和表現型篩檢。隨著製藥公司面臨越來越大的壓力，需要在保持嚴格的安全性和有效性標準的同時縮短藥物研發週期，高通量篩檢(HTS) 技術已成為推動創新的關鍵驅動力。該市場包括流體處理系統和檢測系統等硬體組件，以及整合數據分析和實驗室自動化的軟體解決方案。生物標靶的日益複雜化，以及對個人化和精準醫療需求的不斷成長，進一步凸顯了高通量篩檢平台在現代藥物研發生態系統中的重要性。

市場動態

全球高通量篩檢市場受到多種強勁促進因素的推動，這些因素持續改變藥物研發的格局。主要促進因素包括傳統藥物發現方法成本不斷上升和研發週期不斷延長，迫使製藥公司採用能夠高效處理數百萬種化合物的自動化篩檢技術。慢性疾病（包括癌症、神經系統疾病和代謝性疾病）的日益普遍，推動了對新型治療化合物的需求，從而刺激了對高通量篩選平台的投資。此外，對個人化和精準醫療的日益重視，需要對各種分子標靶進行全面篩檢，這進一步促進了市場擴張。

自動化、小型化和檢測系統的技術進步顯著提高了篩檢能力並降低了營運成本。然而，市場仍存在諸多限制因素。其中之一是建造高通量篩選（HTS）設施需要大量的初始投資，這對於小規模的生物技術公司和學術機構而言是一個障礙。此外，管理和分析高通量實驗數據十分複雜，需要專業知識和先進的軟體解決方案，這帶來了額外的營運挑戰。另外，高昂的維護成本和持續的技術升級需求也會對機構預算造成壓力。儘管存在這些挑戰，但人工智慧（AI）和機器學習技術的融合帶來了巨大的機遇，這些技術能夠最佳化篩檢方案並改善資料解讀。 HTS的應用範圍已從傳統的藥物研發擴展到農業生物技術、化妝品和環境監測等領域，這預示著其擁有廣闊的成長前景。

本次調查的主要特點。

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球高通量篩檢市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球高通量篩檢市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球高通量篩檢市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球高通量篩檢市場：依產品與服務分類，2021-2033年

• 設備（液體處理系統、檢測器和讀取器）
• 試劑和耗材（檢測試劑盒、試劑和化學品）
• 軟體和服務

第5章 全球高通量篩檢市場：依技術分類，2021-2033年

• 基於細胞的檢測
• 生化分析
• 無標定技術
• 晶片實驗室（LOC）和微流體技術
• 超高通量篩檢（uHTS）
• 其他

第6章 全球高通量篩檢市場：依應用領域分類，2021-2033年

• 藥物發現
• 毒性篩檢
• 基因組學和蛋白​​質組學研究
• 生化通路分析
• 目標識別與檢驗

第7章 全球高通量篩檢市場：依最終用戶分類，2021-2033年

• 製藥和生物技術公司
• 學術研究機構
• 受託研究機構（CRO）
• 政府和監管機構
• 其他

第8章 全球高通量篩檢市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第9章 競爭情勢

• Thermo Fisher Scientific
• Revvity（formerly PerkinElmer）
• Agilent Technologies（including BioTek）
• Danaher（Molecular Devices）
• Beckman Coulter Life Sciences
• Tecan Group
• Hamilton Company
• BMG LABTECH
• Yokogawa Electric（CellVoyager）
• SPT Labtech
• HighRes Biosolutions
• Aurora Biomed
• Eppendorf
• Sartorius（ForteBio Octet）
• Azenta Life Sciences（formerly Brooks Life Sciences）

第10章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第11章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

High Throughput Screening Market is estimated to be valued at USD 28.97 Bn in 2026 and is expected to reach USD 59.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.9% from 2026 to 2033.

The global high throughput screening market represents a pivotal segment within the pharmaceutical and biotechnology industry, revolutionizing drug discovery and development processes through automated screening technologies. High throughput screening enables researchers to rapidly conduct millions of chemical, genetic, or pharmacological tests, significantly accelerating the identification of active compounds, antibodies, or genes that modulate particular biomolecular pathways. This sophisticated methodology has become indispensable in modern pharmaceutical research, allowing organizations to process vast libraries of compounds with unprecedented speed and efficiency.

The technology encompasses various screening platforms including cell-based assays, biochemical assays, and phenotypic screening, each serving distinct research objectives. As pharmaceutical companies face mounting pressure to reduce drug development timelines while maintaining rigorous safety and efficacy standards, High Throughput Screening (HTS) technologies have emerged as critical enablers of innovation. The market encompasses hardware components such as liquid handling systems, detection systems, and software solutions that integrate data analysis and laboratory automation. The increasing complexity of biological targets, coupled with the growing demand for personalized medicine and precision therapeutics, has further amplified the significance of high throughput screening platforms in contemporary pharmaceutical research and development ecosystems.

Market Dynamics

The global high throughput screening market is propelled by several compelling drivers that continue to reshape the pharmaceutical research landscape. The primary driver stems from the escalating costs and extended timelines associated with traditional drug discovery methods, compelling pharmaceutical companies to adopt automated screening technologies that can process millions of compounds efficiently. The increasing prevalence of chronic diseases, including cancer, neurological disorders, and metabolic conditions, has intensified the demand for novel therapeutic compounds, thereby driving investment in HTS platforms. Additionally, the growing emphasis on personalized medicine and precision therapeutics necessitates comprehensive screening of diverse molecular targets, further fueling market expansion.

Technological advancements in automation, miniaturization, and detection systems have significantly enhanced screening capabilities while reducing operational costs. However, the market faces notable restraints including the substantial initial capital investment required for establishing HTS facilities, which poses barriers for smaller biotechnology companies and academic institutions. The complexity of data management and analysis from high-throughput experiments requires specialized expertise and sophisticated software solutions, creating additional operational challenges. Furthermore, the high maintenance costs and the need for continuous technological upgrades can strain organizational budgets. Despite these challenges, significant opportunities emerge from the integration of artificial intelligence and machine learning technologies that can optimize screening protocols and enhance data interpretation. The expanding application of HTS beyond traditional pharmaceutical research into areas such as agricultural biotechnology, cosmetics, and environmental monitoring presents lucrative growth prospects.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global high throughput screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity (formerly PerkinElmer), Agilent Technologies (including BioTek), Danaher (Molecular Devices), Beckman Coulter Life Sciences, Tecan Group, Hamilton Company, BMG LABTECH, Yokogawa Electric (CellVoyager), SPT Labtech, HighRes Biosolutions, Aurora Biomed, Eppendorf, Sartorius (ForteBio Octet), and Azenta Life Sciences (formerly Brooks Life Sciences)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global high throughput screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global high throughput screening market

Market Segmentation

• Product And Services Insights (Revenue, USD Bn, 2021 - 2033)
• Instruments (Liquid Handling Systems, Detectors and Readers)
• Reagents and Consumables (Assay Kits, Reagents and Chemicals)
• Software and Services
• Technology Insights (Revenue, USD Bn, 2021 - 2033)
• Cell-based Assays
• Biochemical Assays
• Label-free Technology
• Lab-on-a-Chip (LOC) and Microfluidics
• Ultra-high Throughput Screening (uHTS)
• Others
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Drug Discovery
• Toxicology Screening
• Genomics and Proteomics Research
• Biochemical Pathway Analysis
• Target Identification and Validation
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organizations (CROs)
• Government and Regulatory Agencies
• Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Thermo Fisher Scientific
• Revvity (formerly PerkinElmer)
• Agilent Technologies (including BioTek)
• Danaher (Molecular Devices)
• Beckman Coulter Life Sciences
• Tecan Group
• Hamilton Company
• BMG LABTECH
• Yokogawa Electric (CellVoyager)
• SPT Labtech
• HighRes Biosolutions
• Aurora Biomed
• Eppendorf
• Sartorius (ForteBio Octet)
• Azenta Life Sciences (formerly Brooks Life Sciences)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global High Throughput Screening Market, By Product and Services
  • Global High Throughput Screening Market, By Technology
  • Global High Throughput Screening Market, By Application
  • Global High Throughput Screening Market, By End User
  • Global High Throughput Screening Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global High Throughput Screening Market, By Product and Services, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Instruments (Liquid Handling Systems, Detectors and Readers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Reagents and Consumables (Assay Kits, Reagents and Chemicals)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Software and Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global High Throughput Screening Market, By Technology, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Cell-based Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Biochemical Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Label-free Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Lab-on-a-Chip (LOC) and Microfluidics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Ultra-high Throughput Screening (uHTS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global High Throughput Screening Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Toxicology Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Genomics and Proteomics Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Biochemical Pathway Analysis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Target Identification and Validation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global High Throughput Screening Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Government and Regulatory Agencies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global High Throughput Screening Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product and Services, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Revvity (formerly PerkinElmer)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies (including BioTek)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher (Molecular Devices)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Tecan Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hamilton Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BMG LABTECH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Yokogawa Electric (CellVoyager)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SPT Labtech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• HighRes Biosolutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Aurora Biomed
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eppendorf
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sartorius (ForteBio Octet)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Azenta Life Sciences (formerly Brooks Life Sciences)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us